STAT+: 931 days. The drug approval scandal hiding in plain sight
From the article
You might also wanna read
Health Canada-approved cancer drug lifileucel remains inaccessible to patients awaiting provincial funding decisions
A 37-year-old Ontario father with metastatic melanoma, Alex Shved, is unable to access TIL therapy (lifileucel) — a personalized cancer trea
theglobeandmail.com·9d ago
Alzheimer's Research Impact: Uncovering a 16-Year Setback
A landmark study in Nature that identified a possible cause of Alzheimer’s disease in 2006 influenced research for almost 16 years until con
discovermagazine.com·1y ago
Pancreatic cancer drug daraxonrasib nearly doubles median survival in clinical trials
Scientists gave a standing ovation at a Chicago conference for clinical trial results of daraxonrasib, a pancreatic cancer drug developed by
economist.com·6d ago
Clinical Trial Finds Ozempic Reverses Biological Age by 3.1 Years
The diabetes drug Ozempic has shown significant anti-aging effects in a clinical trial, reversing biological age by an average of 3.1 years
trial.medpath.com·11mo ago
Experimental daraxonrasib pill nearly doubles survival time in advanced pancreatic cancer trial
A new experimental pill called daraxonrasib has shown promising results in extending survival for patients with advanced pancreatic cancer.
cnbc.com·1mo ago
China creates new regulatory pathway to accelerate access to advanced biomedical therapies
China has established a new regulatory "tech track" for advanced therapies like personalized cancer treatments, cell and gene therapies, and
biopharmadive.com·24d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.